Moreover, the most common KRAS genetic alterations in all TCGA cohorts were missense mutations, named “Substitution_exon_coding_non_synonymous” (Figure 2), which had the highest frequencies in PDAC and COAD tumors. Here, KRAS is linked to colon adenocarcinoma.